Ipsen is one of the global leaders in the discovery, development, manufacture and commercialization of neurotoxins. Neuroscience is core to Ipsen’s specialty care business and is integral to the company’s overall strategy and long‐term growth.

Our science

Neuroscience at a glance

Our long‐term commitment to advancing neuroscience and toxins research is evidenced by over 25 years of clinical experience.  We are fully committed to improving people’s lives through safe and effective treatments, support and services in spasticity, movement disorders and specific indications in esthetic medicine.

At a glance

Strategy and expertise

Our neuroscience pipeline

At our R&D centers around the world, and through numerous collaborative projects and partnerships with top academic institutes and investigators, we are pioneering research into neurotoxins.   We have a leading-edge protein engineering expertise in toxins and we are pushing the boundaries of neurotoxin research to provide innovative therapeutic and aesthetic solutions to help patients take back control of their lives.


Clinical trials

 By participating in the tests and treatments outlined in a clinical trial, participants may gain a better understanding of different measurements and what they mean for health in the short-term and long-term.

Learn more
© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2021